Evidence map›Paper›PMID 28758131›Full record

ReviewJournal of diabetes research2017

Treatment of Diabetes Mellitus Using iPS Cells and Spice Polyphenols.

Qi Ge, Liang Chen, Keping Chen

Open access · goldAbstract readReview
In one paragraph

Review in Journal of diabetes research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Qi GeInstitute of Life Science, Jiangsu University, Zhenjiang, Jiangsu 212013, China.ORCID 0000-0002-1748-9768
Liang ChenInstitute of Life Science, Jiangsu University, Zhenjiang, Jiangsu 212013, China.
Keping ChenInstitute of Life Science, Jiangsu University, Zhenjiang, Jiangsu 212013, China.ORCID 0000-0001-5254-2299
Jiangsu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus is a chronic disease that threatens human health. The disease is caused by a metabolic disorder of the endocrine system, and long-term illness can lead to tissue and organ damage to the cardiovascular, endocrine, nervous, and urinary systems. Currently, the disease prevalence is 11.4%, the treatment rate is 48.2%, and the mortality rate is 2.7% worldwide. Comprehensive and effective control of diabetes, as well as the use of insulin, requires further study to develop additional treatment options. Here, we reviewed the current reprogramming of somatic cells using specific factors to induced pluripotent stem (iPS) cells capable of repairing islet

Indexed as

SpicesAnimalsBiomedical ResearchBlood GlucoseDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diffusion of InnovationHumansHypoglycemic AgentsInduced Pluripotent Stem CellsInsulin-Secreting CellsPhytotherapyPlants, MedicinalPolyphenolsTreatment OutcomeBlood GlucoseHypoglycemic AgentsPolyphenols

Identifiers

PMID28758131
PMCPMC5512026
OpenAlexW2729318071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.